Total Body Irradiation (TBI)
Showing 1 - 25 of >10,000
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)
Not yet recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Stage IV Lung Cancer
- Carboplatin
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Oct 25, 2023
Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)
Active, not recruiting
- Metastatic Melanoma
- Skin Cancer
- Aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)
Active, not recruiting
- Leukemia
- +3 more
- Palifermin
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 23, 2023
Acute Leukemia, Myelodysplastic Syndrome Trial in Duarte (Hematopoietic Cell Transplantation, Intensity-Modulated Radiation
Recruiting
- Acute Leukemia
- Myelodysplastic Syndrome
- Hematopoietic Cell Transplantation
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,
Recruiting
- DOCK8 Deficiency
- Reduced-intensity hematopoietic stem cell
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- Fludarabine
- +2 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023
Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)
Recruiting
- Fanconi Anemia
- +2 more
- Total Body Irradiation (TBI) (Plan 1)
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 2, 2022
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Miami (Total Body Irradiation (TBI), Thiotepa, Cyclophosphamide)
Not yet recruiting
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
- Total Body Irradiation (TBI)
- +5 more
-
Miami, FloridaBaptist Health South Florida/Miami Cancer Institute
Nov 28, 2022
GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)
Recruiting
- GATA2
- +2 more
- Allogeneic HSCT
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Immunodeficiency, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute (NCI) (drug, radiation,
Recruiting
- Immunodeficiency
- Hematopoietic Stem Cell Transplantation
- Post-Transplant Cyclophosphamide (PTCY)
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Enrolling by invitation
- Severe Combined Immune Deficiency (SCID)
- Sirolimus
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood
Recruiting
- Hematopoietic Malignancy
- +2 more
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Nov 6, 2023
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,
Active, not recruiting
- Acute Biphenotypic Leukemia
- +18 more
- Cyclophosphamide
- +8 more
-
Aurora, Colorado
- +2 more
Dec 28, 2022
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical
Recruiting
- Hematologic Malignancy
- Fludarabine
-
Atlanta, GeorgiaCaitlin Guzowski
Sep 1, 2022
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- +8 more
- Biospecimen Collection
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 22, 2023
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total
Active, not recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Systemic Scleroderma Trial in Duarte (procedure, drug, radiation)
Recruiting
- Systemic Scleroderma
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 7, 2022
Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan
Active, not recruiting
- Myeloid Malignancies
- +4 more
- Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
- Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Feb 25, 2022
Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute
Not yet recruiting
- Peripheral Blood Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Melphalan
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Hematologic Malignancy Trial in New York (Linac Based VMAT TBI)
Recruiting
- Hematologic Malignancy
- Linac Based VMAT TBI
-
New York, New YorkNYU Langone Health
Jan 13, 2022
Hematological Malignancies Trial in Belgium, Netherlands (Conditioning regimen: TBI + Fludarabine, Conditioning regimen:TLI (8
Completed
- Hematological Malignancies
- Conditioning regimen: TBI + Fludarabine
- Conditioning regimen:TLI (8 Gy) + ATG
-
Leuven, Flamish Brabant, Belgium
- +10 more
Nov 16, 2021
Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)
Recruiting
- Non-Malignant Neoplasm
- Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 29, 2022
Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)
Recruiting
- Living Donor Kidney Transplantation
- Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
-
Palo Alto, California
- +1 more
May 6, 2022
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022